ArticleClinical cancer research : an official journal of the American Association for Cancer Research2020

Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer.

Liye Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.